NN Inc.

Mr. Gentry joined the Company in 1981 and has held various manufacturing management positions within NN. He has served most recently as the Vice President and General Manager of the U.S. Ball & Roller and NN Asia operations. Mr. Hodge has been with NN since 1989 and has served in various operational and management positions in the Company. Mr. Hodge’s latest position has been as the Company’s Corporate Level 3 Manager.

John Lloyd is the Technical Adviser of Immunization Solutions at PATH Children's Vaccine Program (PATH/CVP) in France. He is responsible for having initiated the 'Share' reward system for Immunization Services, the 'Data Quality Audit' for verification of reported immunizations, and the 'Access' approach to raise immunization coverage. Mr. Lloyd has over 30 years of experience designing and evaluating appropriate health technology, primarily in the developing world. Prior to working at PATH/CVP, he served over 20 years as a technical officer for the Expanded Program for Immunizations at the World Health Organization (WHO/EPI) where he was responsible for Cold Chain and Logistic support. He received diplomas in Architecture and Urban Planning from the Architectural Association, London in 1970, and in 1976 completed a fellowship at the Center for Environmental Studies, London. Mr. Lloyd is the author of over 13 publications on immunizations and injection safety in developing nations. Tom McKown is an Executive Officer and Corporate Vice Present of NN, Inc. (a leading bearing components manufacturer). Based in Shanghai, Mr. McKown is responsible for all business activities within the Asia-Pacific region. Prior to joining NN, Mr. McKown held various management positions within firms operating in Hong Kong, Malaysia, PR China, and Taiwan as well as being involved in various development projects in Africa, Latin America, and Central Asia. Peter M. Ndumbe, MD is a native of Cameroon where he trained as an MD at the University of Yaounde. He subsequently went to the University of London where he obtained an MSc in Microbiology and a PhD in Virus Immunology. In 1985 he joined the University of Yaounde as lecturer in Microbiology and Infectious Diseases, where his research interests have been in the control of vaccine preventable diseases. He has conducted two vaccine trials in Cameroon: hepatitis B introduction into the EPI and a comparison of measles vaccines regarding early immunization. Dr Peter Ndumbe is currently Professor and Head of Department of Microbiology and Infectious Diseases, the Dean of the Faculty of Medicine and Biomedical Sciences of the University of Yaounde I, the 2nd Vice President of the Cameroon Academy of Sciences, the Chair of the Task Force on Immunization of the WHO African Region and the Chair of the Scientific and Technical Advisory Committee of the Tropical Diseases Research (TDR) Special Programme. Geoffrey Pasvol, MD, D Phil obtained his Medical Degree from the University of Cape Town in 1972. He was awarded a Rhodes Scholarship to study at The University of Oxford England and obtained his D Phil on the hemoglobinopathies and malaria. In 1983 he was a Research Associate at the Harvard School of Public Health in Boston, USA. He was appointed a Wellcome Senior Fellow at the John Radcliffe Hospital in Oxford in 1984 and in 1989 became Director of the Wellcome Research Unit on the Kenyan coast in Kilifi. He was appointed Professor in Infection & Tropical Medicine, at Imperial College London in 1990 where he has been since. He is a practising clinician in Infectious Diseases and Tropical Medicine. His main research interests are in the pathogenesis of severe malaria as well as the immunology, diagnosis and treatment of tuberculosis. He is currently Director of the Imperial College, Wellcome Centre for Clinical Tropical Medicine which carries out research mainly on tuberculosis and HIV infection in Lima Peru, Mumbai India and Cape Town South Africa.